vs
AGM GROUP HOLDINGS, INC.（AGMH）与Avalon GloboCare Corp.（ALBT）财务数据对比。点击上方公司名可切换其他公司
AGM GROUP HOLDINGS, INC.的季度营收约是Avalon GloboCare Corp.的13.9倍（$4.9M vs $350.1K）
Avalon GloboCare Corp.是一家全球化生物技术与医疗服务提供商，专注于细胞与基因疗法研发、再生医学解决方案落地及转化医学研究创新，业务覆盖北美及亚洲核心市场，为医疗相关主体提供定制化专业服务。
AGMH vs ALBT — 直观对比
营收规模更大
AGMH
是对方的13.9倍
$350.1K
损益表 — Q2 2024 vs Q3 2025
| 指标 | | |
|---|---|---|
| 营收 | $4.9M | $350.1K |
| 净利润 | — | $-254.3K |
| 毛利率 | 4.7% | — |
| 营业利润率 | — | -21.8% |
| 净利率 | — | -72.6% |
| 营收同比 | — | 1.4% |
| 净利润同比 | — | 84.9% |
| 每股收益（稀释后） | $-30.76 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AGMHALBT
| Q3 25 | — | $350.1K | ||
| Q2 25 | — | $350.4K | ||
| Q1 25 | — | $349.8K | ||
| Q4 24 | — | $345.8K | ||
| Q3 24 | — | $345.2K | ||
| Q2 24 | $4.9M | $327.9K | ||
| Q1 24 | — | $314.6K | ||
| Q4 23 | — | $321.3K |
净利润AGMHALBT
| Q3 25 | — | $-254.3K | ||
| Q2 25 | — | $-13.5M | ||
| Q1 25 | — | $-2.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-1.7M | ||
| Q2 24 | — | $-2.1M | ||
| Q1 24 | — | $-1.4M | ||
| Q4 23 | — | $-9.6M |
毛利率AGMHALBT
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 4.7% | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
营业利润率AGMHALBT
| Q3 25 | — | -21.8% | ||
| Q2 25 | — | -1109.6% | ||
| Q1 25 | — | -516.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -367.9% | ||
| Q2 24 | — | -458.8% | ||
| Q1 24 | — | -268.0% | ||
| Q4 23 | — | -3047.1% |
净利率AGMHALBT
| Q3 25 | — | -72.6% | ||
| Q2 25 | — | -3840.9% | ||
| Q1 25 | — | -709.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -486.5% | ||
| Q2 24 | — | -650.2% | ||
| Q1 24 | — | -434.7% | ||
| Q4 23 | — | -2973.7% |
每股收益（稀释后）AGMHALBT
| Q3 25 | — | $-0.06 | ||
| Q2 25 | — | $-6.22 | ||
| Q1 25 | — | $-1.43 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-1.82 | ||
| Q2 24 | $-30.76 | $-2.85 | ||
| Q1 24 | — | $-1.86 | ||
| Q4 23 | — | $-21.18 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.2M | $333.9K |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $4.3M | $-4.5M |
| 总资产 | $70.7M | $9.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AGMHALBT
| Q3 25 | — | $333.9K | ||
| Q2 25 | — | $201.5K | ||
| Q1 25 | — | $1.4M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $1.0M | ||
| Q2 24 | $1.2M | $200.6K | ||
| Q1 24 | — | $305.5K | ||
| Q4 23 | — | $285.4K |
股东权益AGMHALBT
| Q3 25 | — | $-4.5M | ||
| Q2 25 | — | $-7.1M | ||
| Q1 25 | — | $-3.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $5.4M | ||
| Q2 24 | $4.3M | $4.4M | ||
| Q1 24 | — | $6.1M | ||
| Q4 23 | — | $7.4M |
总资产AGMHALBT
| Q3 25 | — | $9.1M | ||
| Q2 25 | — | $8.0M | ||
| Q1 25 | — | $10.6M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $19.6M | ||
| Q2 24 | $70.7M | $19.5M | ||
| Q1 24 | — | $20.3M | ||
| Q4 23 | — | $20.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-590.7K | $-1.4M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AGMHALBT
| Q3 25 | — | $-1.4M | ||
| Q2 25 | — | $-1.2M | ||
| Q1 25 | — | $-1.8M | ||
| Q4 24 | — | $-1.1M | ||
| Q3 24 | — | $-1.9M | ||
| Q2 24 | $-590.7K | $-1.1M | ||
| Q1 24 | — | $-915.7K | ||
| Q4 23 | — | $-796.3K |
自由现金流AGMHALBT
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | $-796.3K |
自由现金流率AGMHALBT
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | -247.8% |
资本支出强度AGMHALBT
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | 0.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
